These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23164713)

  • 21. Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents.
    Hwu JR; Singha R; Hong SC; Chang YH; Das AR; Vliegen I; De Clercq E; Neyts J
    Antiviral Res; 2008 Feb; 77(2):157-62. PubMed ID: 17977606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of new 2'-beta-C-methyl related triciribine analogues as anti-HCV agents.
    Smith KL; Lai VC; Prigaro BJ; Ding Y; Gunic E; Girardet JL; Zhong W; Hong Z; Lang S; An H
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3517-20. PubMed ID: 15177464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and anti-HCV evaluation of 4'(alpha)-ethyl and 2'(beta)-methyl-carbodine analogues.
    Li H; Yoo JC; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2009 Sep; 28(9):809-20. PubMed ID: 20183620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics.
    Perni RB; Chandorkar G; Cottrell KM; Gates CA; Lin C; Lin K; Luong YP; Maxwell JP; Murcko MA; Pitlik J; Rao G; Schairer WC; Van Drie J; Wei Y
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3406-11. PubMed ID: 17482818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and anti-HCV activity of N9,5'-cyclo-3-(beta-D-ribofuranosyl)-8-azapurin-2-one derivatives.
    Hassan AE; Wang P; McBrayer T; Tharnish P; Stuyver L; Otto MJ; Watanabe KA; Schinazi RF
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1531-42. PubMed ID: 16438033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel substituted pyrimidines as HCV replication (replicase) inhibitors.
    Kwong CD; Clark JL; Fowler AT; Geng F; Kezar HS; Roychowdhury A; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Shih NY; Piwinski JJ; Li C; Feld B; Huang HC; Tong X; George Njoroge F; Arasappan A
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1160-4. PubMed ID: 22178556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.
    Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A
    J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
    Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW
    J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and anti-HCV activity of thiourea compounds.
    Kang IJ; Wang LW; Lee CC; Lee YC; Chao YS; Hsu TA; Chern JH
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1950-5. PubMed ID: 19251415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.
    Bennett F; Kezar HS; Girijavallabhan V; Huang Y; Huelgas R; Rossman R; Shih NY; Piwinski JJ; MacCoss M; Kwong CD; Clark JL; Fowler AT; Geng F; Roychowdhury A; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Li C; Chase R; Curry S; Huang HC; Tong X; George Njoroge F; Arasappan A
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5144-9. PubMed ID: 22814211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.
    Stachulski AV; Pidathala C; Row EC; Sharma R; Berry NG; Lawrenson AS; Moores SL; Iqbal M; Bentley J; Allman SA; Edwards G; Helm A; Hellier J; Korba BE; Semple JE; Rossignol JF
    J Med Chem; 2011 Dec; 54(24):8670-80. PubMed ID: 22059983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
    Wittine K; Stipković Babić M; Makuc D; Plavec J; Kraljević Pavelić S; Sedić M; Pavelić K; Leyssen P; Neyts J; Balzarini J; Mintas M
    Bioorg Med Chem; 2012 Jun; 20(11):3675-85. PubMed ID: 22555152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
    Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
    J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication.
    Zhu R; Wang M; Xia Y; Qu F; Neyts J; Peng L
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3321-7. PubMed ID: 18445526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of anti-HCV activity and SAR study of (+)-lycoricidine through targeting of host heat-stress cognate 70 (Hsc70).
    Chen DZ; Jiang JD; Zhang KQ; He HP; Di YT; Zhang Y; Cai JY; Wang L; Li SL; Yi P; Peng ZG; Hao XJ
    Bioorg Med Chem Lett; 2013 May; 23(9):2679-82. PubMed ID: 23511018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5'-Homoneplanocin A inhibits hepatitis B and hepatitis C.
    Yang M; Schneller SW; Korba B
    J Med Chem; 2005 Jul; 48(15):5043-6. PubMed ID: 16033283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
    Oh CH; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides.
    Choi WJ; Kim YM; Kim HO; Lee HW; Kim DE; Park KS; Chong Y; Jeong LS
    Bioorg Med Chem; 2010 Jul; 18(13):4812-20. PubMed ID: 20627592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants.
    Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A; Li X; Zhang S; Zhang YK; Liu Y; Ding CZ; Zhou Y; Plattner JJ; Baker SJ; Bu W; Liu L
    J Med Chem; 2012 Apr; 55(7):3021-6. PubMed ID: 22471376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.